130 related articles for article (PubMed ID: 17113328)
21. Peripheral metabotropic glutamate receptor 5 mediates mechanical hypersensitivity in craniofacial muscle via protein kinase C dependent mechanisms.
Lee JS; Ro JY
Neuroscience; 2007 Apr; 146(1):375-83. PubMed ID: 17306466
[TBL] [Abstract][Full Text] [Related]
22. Peripheral and spinal antihyperalgesic activity of SIB-1757, a metabotropic glutamate receptor (mGLUR(5)) antagonist, in experimental neuropathic pain in rats.
Dogrul A; Ossipov MH; Lai J; Malan TP; Porreca F
Neurosci Lett; 2000 Oct; 292(2):115-8. PubMed ID: 10998562
[TBL] [Abstract][Full Text] [Related]
23. Metabotropic glutamate receptor 5 upregulation in A-fibers after spinal nerve injury: 2-methyl-6-(phenylethynyl)-pyridine (MPEP) reverses the induced thermal hyperalgesia.
Hudson LJ; Bevan S; McNair K; Gentry C; Fox A; Kuhn R; Winter J
J Neurosci; 2002 Apr; 22(7):2660-8. PubMed ID: 11923431
[TBL] [Abstract][Full Text] [Related]
24. Activation of protein kinase C in the spinal cord produces mechanical hyperalgesia by activating glutamate receptors, but does not mediate chronic muscle-induced hyperalgesia.
Sluka KA; Audette KM
Mol Pain; 2006 Apr; 2():13. PubMed ID: 16584564
[TBL] [Abstract][Full Text] [Related]
25. Role of central and peripheral mGluR5 receptors in post-operative pain in rats.
Zhu CZ; Hsieh G; Ei-Kouhen O; Wilson SG; Mikusa JP; Hollingsworth PR; Chang R; Moreland RB; Brioni J; Decker MW; Honore P
Pain; 2005 Mar; 114(1-2):195-202. PubMed ID: 15733645
[TBL] [Abstract][Full Text] [Related]
26. Metabotropic glutamate receptor 5 and dorsal raphe serotonin release in inflammatory pain in rat.
Palazzo E; Genovese R; Mariani L; Siniscalco D; Marabese I; De Novellis V; Rossi F; Maione S
Eur J Pharmacol; 2004 May; 492(2-3):169-76. PubMed ID: 15178361
[TBL] [Abstract][Full Text] [Related]
27. N-antipyrine-3, 4-dichloromaleimide, an effective cyclic imide for the treatment of chronic pain: the role of the glutamatergic system.
Quintão NL; da Silva GF; Antonialli CS; de Campos-Buzzi F; Corrêa R; Filho VC
Anesth Analg; 2010 Mar; 110(3):942-50. PubMed ID: 20185671
[TBL] [Abstract][Full Text] [Related]
28. Acute activation of the spinal cord metabotropic glutamate subtype-5 receptor leads to cold hypersensitivity in the rat.
Hama AT
Neuropharmacology; 2003 Mar; 44(4):423-30. PubMed ID: 12646279
[TBL] [Abstract][Full Text] [Related]
29. Subtype selective antagonism of substantia nigra pars compacta Group I metabotropic glutamate receptors protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo.
Vernon AC; Zbarsky V; Datla KP; Croucher MJ; Dexter DT
J Neurochem; 2007 Nov; 103(3):1075-91. PubMed ID: 17714448
[TBL] [Abstract][Full Text] [Related]
30. Role of metabotropic glutamate receptor subtype 5 (mGluR5) in the maintenance of cold hypersensitivity following a peripheral mononeuropathy in the rat.
Urban MO; Hama AT; Bradbury M; Anderson J; Varney MA; Bristow L
Neuropharmacology; 2003 Jun; 44(8):983-93. PubMed ID: 12763091
[TBL] [Abstract][Full Text] [Related]
31. Effect of a metabotropic glutamate receptor 5 antagonist, MPEP, on the nociceptive response induced by intrathecal injection of excitatory aminoacids, substance P, bradykinin or cytokines in mice.
Jesse CR; Savegnago L; Nogueira CW
Pharmacol Biochem Behav; 2008 Oct; 90(4):608-13. PubMed ID: 18556052
[TBL] [Abstract][Full Text] [Related]
32. Anxiolytic-like effects of group I metabotropic glutamate antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) in rats.
Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E; Pilc A
Pol J Pharmacol; 2000; 52(6):463-6. PubMed ID: 11334240
[TBL] [Abstract][Full Text] [Related]
33. Pain-related behavior following REM sleep deprivation in the rat: influence of peripheral nerve injury, spinal glutamatergic receptors and nitric oxide.
Wei H; Zhao W; Wang YX; Pertovaara A
Brain Res; 2007 May; 1148():105-12. PubMed ID: 17368427
[TBL] [Abstract][Full Text] [Related]
34. Mutational analysis and molecular modeling of the binding pocket of the metabotropic glutamate 5 receptor negative modulator 2-methyl-6-(phenylethynyl)-pyridine.
Malherbe P; Kratochwil N; Zenner MT; Piussi J; Diener C; Kratzeisen C; Fischer C; Porter RH
Mol Pharmacol; 2003 Oct; 64(4):823-32. PubMed ID: 14500738
[TBL] [Abstract][Full Text] [Related]
35. Antidepressant-like effect of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist in the olfactory bulbectomized rats.
Wieronska JM; Szewczyk B; Branski P; Palucha A; Pilc A
Amino Acids; 2002; 23(1-3):213-6. PubMed ID: 12373540
[TBL] [Abstract][Full Text] [Related]
36. Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats.
Kenny PJ; Gasparini F; Markou A
J Pharmacol Exp Ther; 2003 Sep; 306(3):1068-76. PubMed ID: 12805481
[TBL] [Abstract][Full Text] [Related]
37. Neuroprotective effects of the mGlu5R antagonist MPEP towards quinolinic acid-induced striatal toxicity: involvement of pre- and post-synaptic mechanisms and lack of direct NMDA blocking activity.
Popoli P; Pintor A; Tebano MT; Frank C; Pepponi R; Nazzicone V; Grieco R; Pèzzola A; Reggio R; Minghetti L; De Berardinis MA; Martire A; Potenza RL; Domenici MR; Massotti M
J Neurochem; 2004 Jun; 89(6):1479-89. PubMed ID: 15189351
[TBL] [Abstract][Full Text] [Related]
38. Oral administration of Ginkgo biloba extract, EGb-761 inhibits thermal hyperalgesia in rodent models of inflammatory and post-surgical pain.
Biddlestone L; Corbett AD; Dolan S
Br J Pharmacol; 2007 May; 151(2):285-91. PubMed ID: 17375081
[TBL] [Abstract][Full Text] [Related]
39. mGlu5 receptor and protein kinase C implicated in the development and induction of neuropathic pain following chronic ethanol consumption.
Miyoshi K; Narita M; Takatsu M; Suzuki T
Eur J Pharmacol; 2007 May; 562(3):208-11. PubMed ID: 17349994
[TBL] [Abstract][Full Text] [Related]
40. mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)-pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptors.
Movsesyan VA; O'Leary DM; Fan L; Bao W; Mullins PG; Knoblach SM; Faden AI
J Pharmacol Exp Ther; 2001 Jan; 296(1):41-7. PubMed ID: 11123360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
